iotaMotion
St. Paul, US · Founded 2015 · Delaware corporation · 36 employees on LinkedIn · 3 known investors
iotaMotion develops robotic systems for cochlear implant surgery, assisting otolaryngologists in achieving precision beyond human capability. The company serves surgical teams performing cochlear implant procedures and is headquartered in the United States.
Also known as iotaMotion, Inc.
Founders & leadership
iotaMotion was founded in 2015 by Marlan Hansen, MD, Marlan Hansen, and Christopher Kaufmann.
Board
Investors · 3
Reported raises · per SEC filings
Form D private placements$23.4M disclosed across 7 rounds · 2017–2026
▶$1.9MraisedMar 2026 · 1 investors · Other Health CareRule 506(b)
- Vinnie BellanteExecutive Officer
- Eric B. TimkoDirector
- Jeff HopkinsDirector
- Michael LobinskyExecutive Officer, Director
- Marie CalabriaExecutive Officer
- Marlan Hansen, MDExecutive Officer, Director
- Costa NikouExecutive Officer
- Mike BushlackExecutive Officer
- Michael CrookDirector
- Wayne WallaceDirector
- Christopher MartinDirector
- Offering amount
- $10M
- Amount sold
- $1.9M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedJan 2025 · 25 investors · Other Health CareRule 506(b)
- Michael LobinskyExecutive Officer, Director
- Christopher MartinDirector
- Marlan Hansen, MDExecutive Officer, Director
- Wayne WallaceDirector
- Michael CrookDirector
- Eric B. TimkoDirector
- Offering amount
- $15M
- Amount sold
- $6.4M
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.5MraisedApr 2023 · 56 investors · Other Health CareRule 506(b)
- Michael LobinskyExecutive Officer, Director
- Marlan Hansen, MDExecutive Officer, Director
- Eric B. TimkoDirector
- Offering amount
- $15M
- Amount sold
- $8.5M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedMar 2023 · 47 investors · Other Health CareRule 506(b)
- Eric B. TimkoDirector
- Marlan Hansen, MDExecutive Officer, Director
- Michael LobinskyExecutive Officer, Director
- Christopher Kaufmann, MD MSDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- Proceeds to insiders
- $187.5K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedApr 2021 · 32 investors · Other Health CareRule 506(b)
- Marlan HansenExecutive Officer, Director
- Christopher KaufmannExecutive Officer, Director
- Eric B. TimkoDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Proceeds to insiders
- $187.5K
- First sale
- Feb 2021
- Incorporated
- Corporation, De
- Federal exemptions
- 06b
▶$100KraisedApr 2019 · 1 investors · Other Health CareRule 506(b)
- Christopher Kaufmann, MD MSExecutive Officer, Director
- Eric B. TimkoExecutive Officer, Director
- Marlan Hansen, MDExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $100K
- Proceeds to insiders
- $210.5K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$2.1MraisedOct 2018 · 19 investors · Other Health CareRule 506(b)
- Marlan Hansen, MDExecutive Officer, Director
- Eric B. TimkoDirector
- Christopher Kaufmann, MD MSExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $2.1M
- Minimum investment
- $50K
- Proceeds to insiders
- $230K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026iotaMotion develops robotic assistance technology for cochlear implant surgery. Its principal product, the iotaSOFT Insertion System, is described as an open-platform robotic-assisted system intended to reduce surgical variability by controlling the speed at which a cochlear implant electrode array is inserted into the cochlea.
The company frames the clinical rationale for the system around the fragility of the cochlea: a slow and consistent electrode array insertion is said to reduce maximum insertion force and force variation relative to manual insertion techniques, helping preserve delicate cochlear structures and minimize trauma. iotaMotion positions the technology as serving three groups — surgeons (controlled insertion), hospitals (cost-effective implementation) and patients (standardized outcomes) — and publishes supporting-evidence and introductory brochures for clinicians and patients, along with continuing-education courses for audiologists distributed through AudiologyOnline.
Business model
iotaMotion supplies a robotic-assisted insertion system to hospitals and surgical teams performing cochlear implantation, describing the platform as open (usable alongside existing implant technology) and emphasizing cost-effective implementation for hospitals.
▸Full profile — market position, technology, go-to-market
Market position
iotaMotion cites World Health Organization figures that more than 430 million people worldwide experience disabling hearing loss, of whom more than 60 million have severe or greater impairment — the population it identifies as most likely to benefit from cochlear implants — and positions robotic assistance as a way to expand access by reducing patient barriers such as fear of surgery.
Technology
The iotaSOFT Insertion System is an open-platform, robotic-assisted device that controls the speed of cochlear implant electrode array insertion. The company states that slow, consistent insertion lowers maximum force and force variation compared with manual insertion, supporting preservation of cochlear structures.
Go-to-market
The company markets directly to surgeons, hospitals and patients through product literature (supporting-evidence and introductory brochures) and offers continuing-education credits to audiologists via AudiologyOnline courses.
Cochlear implant surgeons and their surgical teams, hospitals performing cochlear implantation, audiologists, and cochlear implant patients.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 2
by search overlap
Companies competing with iotaMotion for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Science Foundation | Phase I | 2016 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Legal entities · 1
corporate structureIn the news
▸Research sources · 1
primary sources listed
- iotaMotioniotamotion.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does iotaMotion do?
- iotaMotion makes the iotaSOFT robotic-assisted system for controlled cochlear implant electrode array insertion.
- Who founded iotaMotion?
- iotaMotion was founded by Marlan Hansen, MD, Marlan Hansen, Christopher Kaufmann in 2015.
- Who are iotaMotion's investors?
- iotaMotion's investors include ISA Ventures, Mutual Capital Partners, Next Level Ventures.
- How much funding has iotaMotion raised?
- iotaMotion has disclosed $23.4M raised across 7 rounds.
- Where is iotaMotion headquartered?
- iotaMotion is headquartered in St. Paul, US.